1. International Conference on Harmonisation. Harmonized Tripartite Guideline: Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. Step 4. Geneva, Switzerland: International Conference on Harmonisation; October 1999.
2. International Conference on Harmonisation. Harmonized Tripartite Guideline: Q6B, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Biotechnological/Biological Products. Step 4. Geneva, Switzerland: International Conference on Harmonisation; March 1999.
3. International Conference on Harmonisation. Harmonized Tripartite Guideline: Q1(R), Stability Testing of New Drug Substances and Products (Revised guideline). Step 4. Geneva, Switzerland: International Conference on Harmonisation; November 2000.
4. Davis GC, Murphy JR, Weisman DA, Andersen SA, Hofer JD. Rational approaches to specification setting: An opportunity for harmonization. Pharma Tech. September 1991.
5. US Food and Drug Administration. Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics. Rockville, MD: US Food and Drug Administration, Center for Drugs and Biologics, Office of Drug Research and Review; 1987.